Advertisement

Topics

Sekisui Diagnostics Company Profile

00:56 EST 18th January 2017 | BioPortfolio

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices throughout the world. Formerly known as Genzyme Diagnostics, Sekisui Diagnostics has over 30 years of experience developing, manufacturing and commercializing a variety of unique products which meet the needs of the global diagnostics market. Learn more about Sekisui Diagnostics at www.sekisuidiagnostics.com.


News Articles [805 Associated News Articles listed on BioPortfolio]

Sekisui Diagnostics expands point of care diagnostics offering with FastPack IP system

Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics product line through a recent partnership agreement with Qualigen.

Sekisui Diagnostics launches bacterial vaginosis rapid test in Europe, Middle East and North Africa

Global diagnostics firm Sekisui Diagnostics has introduced OSOM BVBLUE test in Europe, Middle East and North Africa.

Sekisui Diagnostics Announces Launch of OSOM® BVBLUE® Rapid Test for Bacterial Vaginosis in Europe, Middle East and North Africa

LEXINGTON, Mass., Jan. 11, 2017 /PRNewswire/ -- Today, Sekisui Diagnostics announces the launch of the OSOM® BVBLUE® Test in Europe, Middle East and North Africa.  The OSOM® BVBLUE® Test, whi...

Sekisui XenoTech expands hepatotoxicity testing

Sekisui XenoTech has added additional hepatotoxicity screening assays and methodologies to the company’s existing cytotoxicity contract research services. Cytotoxicity studies assess the risk tha...

US FDA asks Sekisui how it will fix API test data problems at Japan plant

The US FDA has asked Sekisui Medical to specify how it will resolve data integrity issues uncovered during an inspection of its API plant in Hachimantai, Japan in June.

CRO Sekisui XenoTech adds new test systems to offerings

Sekisui XenoTech  now offers hepatic human lysosomes  and rat tritosomes  as standard test systems for in vitro drug development.

Sekisui Diagnostics Expands Point of Care Diagnostics offering with the FastPack® IP System

Timely, accurate immunoassay testing for physician offices LEXINGTON, Mass., Aug. 2, 2016 /PRNewswire/ -- Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics ...

Sekisui Diagnostics presenta innovadores análisis de sífilis completamente automatizados con ...

"Siguiendo nuestro compromiso con el desarrollo continuo de pruebas que puedan ayudar a mejorar el cuidado del paciente, la nueva prueba de sífilis SEKURE® ofrece Read more...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [266 Associated PubMed Articles listed on BioPortfolio]

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.

The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.

Resistance diagnosis and the changing economics of antibiotic discovery.

Point-of-care diagnostics that can determine an infection's antibiotic sensitivity increase the profitability of new antibiotics that enjoy patent protection, even when such diagnostics reduce the qua...

Next-Generation Sequencing in Cancer Diagnostics.

This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.

Current position of diagnostics and surgical treatment for upper tract urothelial carcinoma.

The applicability of urinary biomarkers and optical diagnostics in upper urinary tract carcinoma (UUTUC) are increasingly debated. To receive insight in the opinion of the urological community involve...

Point-of-Care Diagnostics for Improving Maternal Health in South Africa.

Improving maternal health is a global priority, particularly in high HIV-endemic, resource-limited settings. Failure to use health care facilities due to poor access is one of the main causes of mater...

Clinical Trials [125 Associated Clinical Trials listed on BioPortfolio]

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions

The "Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions (RACE-IT)" represents a mono-centric registry of patients being hospitalized su...

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Companies [878 Associated Companies listed on BioPortfolio]

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

ERBA Diagnostics Inc.

ERBA Diagnostics, Inc. (www.erbadiagnostics.com), headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distrib...

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

More Information about "Sekisui Diagnostics" on BioPortfolio

We have published hundreds of Sekisui Diagnostics news stories on BioPortfolio along with dozens of Sekisui Diagnostics Clinical Trials and PubMed Articles about Sekisui Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sekisui Diagnostics Companies in our database. You can also find out about relevant Sekisui Diagnostics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record